View this email in your browser
Ysios Capital presents its third fund of €200 million in Barcelona to invest in disruptive therapeutic productsRead
Ona Therapeutics raises €30 million, a Top 5 Series A funding in EuropeRead
Catalan vice-president Pere Aragonès meets with stakeholders, companies and investors in the life sciences sectorRead
Grifols starts production of its immunoglobulin against Covid-19
Read
Boehringer acquires Northern Biologics cancer pipeline
Alta Life Sciences invests €7.6 M in Accure Therapeutics
Almirall enters the IBEX 35 (Spain Stock Market)
Pact to make Catalonia a leader among knowledge societies
Minoryx begins a phase II trial with leriglitazone for cALD treatment
Vytrus Biotech launches the first biological deodorant
Aquilino Peña, new president of the Spanish Venture Capital Association
Palobiofarma to receive funding from CDTI for Covid-19 drug
Anaxomics artificial intelligence used for malaria and diabetes studiesRead
Reusable mask created in Catalonia for Covid outbreaks
Mitelos and Faes Farma reach deal to market new spray for external otitisRead
If you missed the CataloniaBioHT Lessons Learned session, here is the video
Strategic decisions of Life Sciences companies in the face of the Covid-19 (In Catalan / Spanish)
Lessons Learned Session
Improving human health through artificial intelligence
18 June, 2020 (online)
REGISTER TODAY
Open Innovation Forum
This program allows companies to share their innovation challenges
15 July, 2020 (online)
Ferrer 4 Future program
Ferrer pharmaceutical company presents the 2nd edition of its innovation program in e-Health
Call open until 28 August, 2020
MORE
More offers on our website
CataloniaBio & HealthTech - Baldiri Reixac, 4-8, Torre I (PCB) - 0828 Barcelona© All rights reserved
Email enviat a comunicacio@catalonia.health donar-me de baixa de la llista CataloniaBio & HealthTech
